Antisoma PLC to Present at Canaccord Global Growth Conference

LONDON--(Marketwire - August 06, 2010) -


6 August 2010, London, UK, and Cambridge, MA: Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that senior executive Dr Michael Boss will present at the 30th Annual Canaccord Global Growth Conference in Boston on Wednesday August 11 at 1pm local time (6pm BST).

A webcast of the presentation will be available on Antisoma’s website at http://www.antisoma.com/asm/media/webcast/

For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.

Enquiries: Alison Saville Senior Marketing and Communications Executive Antisoma plc +44 (0)20 3249 2100 

Background on Antisoma

Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visit www.antisoma.com for further information about Antisoma.


[HUG#1436343]


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

All reproduction for further distribution is prohibited.

Source: Antisoma plc via Thomson Reuters ONE

MORE ON THIS TOPIC